Development of therapy approach in Patient with Chronic Granulocity Leukemia: Case Report

1. Spiers AS. Clinical manifestations of chronic granulocytic leukemia. Semin Oncol. 1995 Aug;22(4):380–95. SpiersAS Clinical manifestations of chronic granulocytic leukemia Semin Oncol. 1995 Aug 22 4 380 95 Search in Google Scholar

2. Saußele S, Silver RT. Management of chronic myeloid leukemia in blast crisis. Ann Hematol. 2015 Apr;94 Suppl 2:S159–65. doi: 10.1007/s00277-015-2324-0. SaußeleS SilverRT Management of chronic myeloid leukemia in blast crisis Ann Hematol. 2015 Apr 94 Suppl 2 S159 65 10.1007/s00277-015-2324-0 Open DOISearch in Google Scholar

3. Zhou H, Xu R. Leukemia stem cells: the root of chronic myeloid leukemia. Protein Cell. 2015 Jun;6(6):403–12. doi: 10.1007/s13238-015-0143-7. ZhouH XuR Leukemia stem cells: the root of chronic myeloid leukemia Protein Cell. 2015 Jun 6 6 403 12 10.1007/s13238-015-0143-7 Open DOISearch in Google Scholar

4. Goldman JM. Chronic myeloid leukemia: a historical perspective. Semin Hematol. 2010 Oct;47(4):302–11. doi: 10.1053/j.seminhematol.2010.07.001. GoldmanJM Chronic myeloid leukemia: a historical perspective Semin Hematol. 2010 Oct 47 4 302 11 10.1053/j.seminhematol.2010.07.001 Open DOISearch in Google Scholar

5. https://www.cancer.gov/publications/cancerterms/def/chronic-granulocytic-leukemia https://www.cancer.gov/publications/cancerterms/def/chronic-granulocytic-leukemia Search in Google Scholar

6. Eden RE, Coviello JM. Cancer, Leukemia, Myelogenous, Chronic (CML, Chronic Granulocytic Leukemia). 2018 Oct 27. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan- Available from http://www.ncbi.nlm.nih.gov/books/NBK531459/ EdenRE CovielloJM Cancer, Leukemia, Myelogenous, Chronic (CML, Chronic Granulocytic Leukemia) 2018 Oct 27 StatPearls [Internet] Treasure Island (FL) StatPearls Publishing 2018 Jan- Available from http://www.ncbi.nlm.nih.gov/books/NBK531459/

7. Shao X, Chen D, Xu P, Peng M, Guan C, Xie P, Yuan C, Chen B. Primary Philadelphia chromosome positive acute myeloid leukemia: A case report. Medicine (Baltimore). 2018 Nov;97(44):e12949. doi: 10.1097/MD.0000000000012949. ShaoX ChenD XuP PengM GuanC XieP YuanC ChenB Primary Philadelphia chromosome positive acute myeloid leukemia: A case report Medicine (Baltimore) 2018 Nov 97 44 e12949 10.1097/MD.0000000000012949 Open DOISearch in Google Scholar

8. Kuan JW, Su AT, Leong CF, Osato M, Sashida G. Systematic review of pre-clinical chronic myeloid leukaemia. Int J Hematol. 2018 Nov;108(5):465–484. doi: 10.1007/s12185-018-2528-x. KuanJW SuAT LeongCF OsatoM SashidaG Systematic review of pre-clinical chronic myeloid leukaemia Int J Hematol. 2018 Nov 108 5 465 484 10.1007/s12185-018-2528-x Open DOISearch in Google Scholar

9. Marchetti M. Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review. Expert Rev Pharmacoecon Outcomes Res. 2017 Oct;17(5):469–480. doi: 10.1080/14737167.2017.1366858. MarchettiM Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review Expert Rev Pharmacoecon Outcomes Res. 2017 Oct 17 5 469 480 10.1080/14737167.2017.1366858 Open DOISearch in Google Scholar

10. Rajpal S, Nampoothiri RV, Sreedharanunni S, Parihar M, Malhotra P, Varma N. Granulocytic dysplasia: an indicator of clonal evolution in patients with chronic myeloid leukemia. Blood Res. 2018 Jun;53(2):180–181. doi: 10.5045/br.2018.53.2.180. RajpalS NampoothiriRV SreedharanunniS PariharM MalhotraP VarmaN Granulocytic dysplasia: an indicator of clonal evolution in patients with chronic myeloid leukemia Blood Res. 2018 Jun 53 2 180 181 10.5045/br.2018.53.2.180 Open DOISearch in Google Scholar

11. Bhatia R. Novel approaches to therapy in CML. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):115–120. doi: 10.1182/asheducation-2017.1.115. BhatiaR Novel approaches to therapy in CML Hematology Am Soc Hematol Educ Program. 2017 Dec 8 2017 1 115 120 10.1182/asheducation-2017.1.115 Open DOISearch in Google Scholar

12. Kota VK, Kong JH, Arellano M, El Rassi F, Gaddh M, Heffner LT, Winton EF, Jillella AP, McLemore ML, Khoury HJ. Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):e71–e73. doi: 10.1016/j.clml.2017.09.004. KotaVK KongJH ArellanoM ElRassi F GaddhM HeffnerLT WintonEF JillellaAP McLemoreML KhouryHJ Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib Clin Lymphoma Myeloma Leuk. 2017 Dec 17 12 e71 e73 10.1016/j.clml.2017.09.004 Open DOISearch in Google Scholar

13. Kwak JY, Kim SH, Oh SJ, Zang DY, Kim H, Kim JA, Do YR, Kim HJ, Park JS, Choi CW, Lee WS, Mun YC, Kong JH, Chung JS, Shin HJ, Kim DY, Park J, Jung CW, Bunworasate U, Comia NS, Jootar S, Reksodiputro AH, Caguioa PB, Lee SE, Kim DW. Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia. Clin Cancer Res. 2017 Dec 1;23(23):7180–7188. doi: m10.1158/1078-0432.CCR-17-0957 . KwakJY KimSH OhSJ ZangDY KimH KimJA DoYR KimHJ ParkJS ChoiCW LeeWS MunYC KongJH ChungJS Shin HJ Kim DY Park J Jung CW Bunworasate U Comia NS Jootar S Reksodiputro AH Caguioa PB Lee SE Kim DW Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Clin Cancer Res. 2017 Dec 1 23 23 7180 7188 m10.1158/1078-0432.CCR-17-0957 Open DOI

14. Tojo A, Kyo T, Yamamoto K, Nakamae H, Takahashi N, Kobayashi Y, Tauchi T, Okamoto S, Miyamura K, Hatake K, Iwasaki H, Matsumura I, Usui N, Naoe T, Tugnait M, Narasimhan NI, Lustgarten S, Farin H, Haluska F, Ohyashiki K. Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase ½ study. Int J Hematol. 2017 Sep;106(3):385–397. doi: 10.1007/s12185-017-2238-9. TojoA KyoT YamamotoK NakamaeH TakahashiN KobayashiY TauchiT OkamotoS MiyamuraK HatakeK IwasakiH MatsumuraI UsuiN NaoeT TugnaitM NarasimhanNI LustgartenS FarinH HaluskaF Ohyashiki K. Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase ½ study Int J Hematol. 2017 Sep 106 3 385 397 10.1007/s12185-017-2238-9 Open DOISearch in Google Scholar

15. Fischer JT, Ho AD, Wilhelm M, Goebeler ME, et al. German CML Study Group. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment. Leukemia. 2016 Mar;30(3):562–9. doi: 10.1038/leu.2015.281. FischerJT HoAD WilhelmM GoebelerME German CML Study Group Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment Leukemia 2016 Mar 30 3 562 9 10.1038/leu.2015.281 Open DOISearch in Google Scholar

16. Jiang Q, Zhao D, Jin J, Wu D, Meng F, Hu J, Liu B, DU X, Liu T, Li Y, Hou M, Han X, Shen Z, Ma J. [A prospective, multi-centre clinical trial to evaluate the early clinical efficacy and safety of a generic imatinib in treating patients with chronic phase of chronic myelogenous leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2015 Aug;36(8):651–5. doi: 10.3760/cma.j.issn.0253-2727.2015.08.005. JiangQ ZhaoD JinJ WuD MengF HuJ LiuB DUX LiuT LiY HouM HanX ShenZ MaJ [A prospective, multi-centre clinical trial to evaluate the early clinical efficacy and safety of a generic imatinib in treating patients with chronic phase of chronic myelogenous leukemia] Zhonghua Xue Ye Xue Za Zhi. 2015 Aug 36 8 651 5 10.3760/cma.j.issn.0253-2727.2015.08.005 Open DOISearch in Google Scholar

17. Hochhaus A, Rosti G, Cross NC, Steegmann JL, et al. Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study. Leukemia. 2016 Jan;30(1):57–64. doi: 10.1038/leu.2015.270. HochhausA RostiG CrossNC SteegmannJL Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study Leukemia 2016 Jan 30 1 57 64 10.1038/leu.2015.270 Open DOISearch in Google Scholar